Importantly, IGFBP2 accumulation is prominent in the nucleus of LAM cells in vitro, in xenograft tumors and lung metastatic lesions of Tsc2-null ELT3 cells in SCID mice treated with estradiol, and in clinical specimens of pulmonary LAM. Here, IGFBP2 is linked to lymphangioleiomyomatosis.